GB1311573A - Quinazolinedione derivatives - Google Patents

Quinazolinedione derivatives

Info

Publication number
GB1311573A
GB1311573A GB1023371A GB1023371A GB1311573A GB 1311573 A GB1311573 A GB 1311573A GB 1023371 A GB1023371 A GB 1023371A GB 1023371 A GB1023371 A GB 1023371A GB 1311573 A GB1311573 A GB 1311573A
Authority
GB
United Kingdom
Prior art keywords
compounds
alkylating
april
acylating agent
above formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1023371A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Publication of GB1311573A publication Critical patent/GB1311573A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB1023371A 1970-04-27 1971-04-20 Quinazolinedione derivatives Expired GB1311573A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3649470 1970-04-27

Publications (1)

Publication Number Publication Date
GB1311573A true GB1311573A (en) 1973-03-28

Family

ID=12471364

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1023371A Expired GB1311573A (en) 1970-04-27 1971-04-20 Quinazolinedione derivatives

Country Status (4)

Country Link
CH (1) CH546243A (enrdf_load_stackoverflow)
DE (1) DE2120663C3 (enrdf_load_stackoverflow)
FR (1) FR2100623B1 (enrdf_load_stackoverflow)
GB (1) GB1311573A (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016166A (en) * 1973-12-14 1977-04-05 Hisamitsu Pharmaceutical Co., Inc. 1-Nitrophenylquinazoline-2,4(1H,3H)-diones
EP1667685A4 (en) * 2003-09-23 2009-04-29 Merck & Co Inc INHIBITORS OF QUINAZOLINE-BASED POTASSIUM CANAL

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002302894A1 (en) * 2001-06-19 2003-01-02 Warner-Lambert Company Llc Quinazolinediones as antibacterial agents

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016166A (en) * 1973-12-14 1977-04-05 Hisamitsu Pharmaceutical Co., Inc. 1-Nitrophenylquinazoline-2,4(1H,3H)-diones
EP1667685A4 (en) * 2003-09-23 2009-04-29 Merck & Co Inc INHIBITORS OF QUINAZOLINE-BASED POTASSIUM CANAL
US7906521B2 (en) 2003-09-23 2011-03-15 Merck Sharp & Dohme Corp. Quinazoline potassium channel inhibitors

Also Published As

Publication number Publication date
DE2120663C3 (de) 1975-09-18
DE2120663B2 (de) 1975-02-06
DE2166614A1 (de) 1974-10-31
FR2100623A1 (enrdf_load_stackoverflow) 1972-03-24
DE2120663A1 (de) 1971-11-11
DE2166614B2 (de) 1976-09-16
CH546243A (de) 1974-02-28
FR2100623B1 (enrdf_load_stackoverflow) 1976-04-16

Similar Documents

Publication Publication Date Title
ES408226A1 (es) Procedimiento para preparar acidos quinazolin-4-il?indol-3-ilaceticos.
NO930693D0 (no) Mometasonfuroatmonohydrat, fremgangsmaate for fremstillingav dette og farmasoeytiske preprater
ES419355A1 (es) Un procedimiento para la preparacion de una composicion re-ductora del nivel de colesterol en la sangre.
ES452737A1 (es) Un procedimiento para preparar compuestos 2-anol-3-fenilben-zotiofeno.
ES8307494A1 (es) "un procedimiento para preparar una composicion farmaceutica que proporciona un efecto anti-inflamatorio y analgesico junto con un dano gastrico minimizado".
ES389180A1 (es) Procedimiento para la preparacion de derivados de la dihi- dro-3,4 isoquinoleina.
CA970683A (en) Compositions of matter comprising solution of crude 1,2-benzisothiazolone
GB1311573A (en) Quinazolinedione derivatives
ES2100396T3 (es) Derivados de 17-(3-furil)- y 17-(4-piridazinil)-5beta,14beta-androstano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que los contienen.
ES371323A1 (es) Procedimiento para la preparacion de derivados de piridoin-dol.
GB1357449A (en) Furoquinolinecarboxylic acid derivatives
GB1343119A (en) Flavone derivatives
GB1252870A (enrdf_load_stackoverflow)
GB1309679A (en) Substituted sulphonanilides
GB1252847A (enrdf_load_stackoverflow)
GB1184044A (en) Nitrofuryl-Oxadiazole Derivatives
GB1264798A (enrdf_load_stackoverflow)
GB1325770A (en) Pyrimidopyridazine derivatives
ES429818A1 (es) Procedimiento para preparar derivados del acido tricloroa- cetamido-7 desacetoxi-3 cefalosporanico.
GB1332697A (en) Benzodiazepine derivatives
GB1355663A (en) 19-nortestosterone 17- -p-substituted phenoxy-acetates
ES423586A1 (es) Procedimiento para preparar derivados de ditiino (1,4) (2,3-c) pirrol.
GB1272340A (en) Derivatives of neriifolin
GB1390487A (en) Pharmaceutical compositions containing diphenylmethane deri vatives
GB1252861A (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee